vs

Side-by-side financial comparison of COHEN & STEERS, INC. (CNS) and DocGo Inc. (DCGO). Click either name above to swap in a different company.

COHEN & STEERS, INC. is the larger business by last-quarter revenue ($143.8M vs $74.9M, roughly 1.9× DocGo Inc.). COHEN & STEERS, INC. runs the higher net margin — 24.3% vs -190.0%, a 214.2% gap on every dollar of revenue. On growth, COHEN & STEERS, INC. posted the faster year-over-year revenue change (2.9% vs -38.0%). DocGo Inc. produced more free cash flow last quarter ($-12.0M vs $-126.4M). Over the past eight quarters, COHEN & STEERS, INC.'s revenue compounded faster (8.3% CAGR vs -37.5%).

Cohen & Steers is an American investment management company. It focuses on investments in real estate securities via real estate investment trusts (REIT) and alternative income via preferred securities.

DocGo Inc. is a U.S.-headquartered mobile healthcare and on-demand medical service provider. It offers a range of solutions including in-home urgent care, diagnostic testing, telehealth consultations, and corporate wellness programs, serving individual patients, health systems, enterprise clients, and public sector organizations across North America.

CNS vs DCGO — Head-to-Head

Bigger by revenue
CNS
CNS
1.9× larger
CNS
$143.8M
$74.9M
DCGO
Growing faster (revenue YoY)
CNS
CNS
+40.9% gap
CNS
2.9%
-38.0%
DCGO
Higher net margin
CNS
CNS
214.2% more per $
CNS
24.3%
-190.0%
DCGO
More free cash flow
DCGO
DCGO
$114.5M more FCF
DCGO
$-12.0M
$-126.4M
CNS
Faster 2-yr revenue CAGR
CNS
CNS
Annualised
CNS
8.3%
-37.5%
DCGO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CNS
CNS
DCGO
DCGO
Revenue
$143.8M
$74.9M
Net Profit
$34.9M
$-142.3M
Gross Margin
Operating Margin
28.0%
-139.6%
Net Margin
24.3%
-190.0%
Revenue YoY
2.9%
-38.0%
Net Profit YoY
-23.9%
-1761.4%
EPS (diluted)
$0.67
$-1.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CNS
CNS
DCGO
DCGO
Q4 25
$143.8M
$74.9M
Q3 25
$141.7M
$70.8M
Q2 25
$136.1M
$80.4M
Q1 25
$134.5M
$96.0M
Q4 24
$139.8M
$120.8M
Q3 24
$133.2M
$138.7M
Q2 24
$121.7M
$164.9M
Q1 24
$122.7M
$192.1M
Net Profit
CNS
CNS
DCGO
DCGO
Q4 25
$34.9M
$-142.3M
Q3 25
$41.7M
$-27.8M
Q2 25
$36.8M
$-11.2M
Q1 25
$39.8M
$-9.4M
Q4 24
$45.8M
$-7.6M
Q3 24
$39.7M
$5.5M
Q2 24
$31.8M
$6.5M
Q1 24
$34.0M
$11.2M
Operating Margin
CNS
CNS
DCGO
DCGO
Q4 25
28.0%
-139.6%
Q3 25
34.5%
-59.3%
Q2 25
31.8%
-21.7%
Q1 25
33.6%
-14.6%
Q4 24
35.3%
-6.2%
Q3 24
33.7%
7.3%
Q2 24
31.5%
6.2%
Q1 24
32.8%
8.3%
Net Margin
CNS
CNS
DCGO
DCGO
Q4 25
24.3%
-190.0%
Q3 25
29.4%
-39.2%
Q2 25
27.1%
-13.9%
Q1 25
29.6%
-9.8%
Q4 24
32.8%
-6.3%
Q3 24
29.8%
4.0%
Q2 24
26.1%
4.0%
Q1 24
27.7%
5.8%
EPS (diluted)
CNS
CNS
DCGO
DCGO
Q4 25
$0.67
$-1.36
Q3 25
$0.81
$-0.28
Q2 25
$0.72
$-0.11
Q1 25
$0.77
$-0.09
Q4 24
$0.89
$-0.03
Q3 24
$0.77
$0.05
Q2 24
$0.63
$0.06
Q1 24
$0.68
$0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CNS
CNS
DCGO
DCGO
Cash + ST InvestmentsLiquidity on hand
$145.5M
$51.0M
Total DebtLower is stronger
$235.6K
Stockholders' EquityBook value
$562.0M
$144.0M
Total Assets
$876.7M
$217.1M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CNS
CNS
DCGO
DCGO
Q4 25
$145.5M
$51.0M
Q3 25
$98.1M
$73.4M
Q2 25
$95.4M
$104.2M
Q1 25
$65.2M
$79.0M
Q4 24
$183.0M
$89.2M
Q3 24
$106.5M
$89.5M
Q2 24
$122.0M
$66.1M
Q1 24
$99.5M
$41.2M
Total Debt
CNS
CNS
DCGO
DCGO
Q4 25
$235.6K
Q3 25
$249.9K
Q2 25
$12.6K
Q1 25
$15.1K
Q4 24
$17.7K
Q3 24
$47.7K
Q2 24
$52.8K
Q1 24
$60.1K
Stockholders' Equity
CNS
CNS
DCGO
DCGO
Q4 25
$562.0M
$144.0M
Q3 25
$550.3M
$270.5M
Q2 25
$528.5M
$297.3M
Q1 25
$507.7M
$309.3M
Q4 24
$511.7M
$320.9M
Q3 24
$491.0M
$325.2M
Q2 24
$463.2M
$315.2M
Q1 24
$378.9M
$311.3M
Total Assets
CNS
CNS
DCGO
DCGO
Q4 25
$876.7M
$217.1M
Q3 25
$801.6M
$353.8M
Q2 25
$751.0M
$408.3M
Q1 25
$834.9M
$430.8M
Q4 24
$812.4M
$455.6M
Q3 24
$727.8M
$493.9M
Q2 24
$784.1M
$488.2M
Q1 24
$680.7M
$490.7M
Debt / Equity
CNS
CNS
DCGO
DCGO
Q4 25
0.00×
Q3 25
0.00×
Q2 25
0.00×
Q1 25
0.00×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CNS
CNS
DCGO
DCGO
Operating Cash FlowLast quarter
$-120.4M
$-10.5M
Free Cash FlowOCF − Capex
$-126.4M
$-12.0M
FCF MarginFCF / Revenue
-87.9%
-16.0%
Capex IntensityCapex / Revenue
4.2%
2.0%
Cash ConversionOCF / Net Profit
-3.45×
TTM Free Cash FlowTrailing 4 quarters
$-253.6M
$29.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CNS
CNS
DCGO
DCGO
Q4 25
$-120.4M
$-10.5M
Q3 25
$55.1M
$1.7M
Q2 25
$-67.6M
$33.6M
Q1 25
$-108.9M
$9.7M
Q4 24
$96.7M
$12.7M
Q3 24
$25.6M
$31.1M
Q2 24
$31.4M
$36.9M
Q1 24
$4.9M
$-10.6M
Free Cash Flow
CNS
CNS
DCGO
DCGO
Q4 25
$-126.4M
$-12.0M
Q3 25
$52.6M
$782.6K
Q2 25
$-69.8M
$32.9M
Q1 25
$-110.0M
$8.2M
Q4 24
$85.0M
$12.0M
Q3 24
$24.2M
$30.2M
Q2 24
$27.1M
$35.9M
Q1 24
$537.0K
$-11.6M
FCF Margin
CNS
CNS
DCGO
DCGO
Q4 25
-87.9%
-16.0%
Q3 25
37.1%
1.1%
Q2 25
-51.3%
40.9%
Q1 25
-81.8%
8.5%
Q4 24
60.8%
9.9%
Q3 24
18.2%
21.8%
Q2 24
22.3%
21.7%
Q1 24
0.4%
-6.0%
Capex Intensity
CNS
CNS
DCGO
DCGO
Q4 25
4.2%
2.0%
Q3 25
1.8%
1.2%
Q2 25
1.6%
0.9%
Q1 25
0.8%
1.5%
Q4 24
8.3%
0.6%
Q3 24
1.1%
0.7%
Q2 24
3.5%
0.6%
Q1 24
3.5%
0.5%
Cash Conversion
CNS
CNS
DCGO
DCGO
Q4 25
-3.45×
Q3 25
1.32×
Q2 25
-1.84×
Q1 25
-2.74×
Q4 24
2.11×
Q3 24
0.65×
5.67×
Q2 24
0.99×
5.65×
Q1 24
0.14×
-0.95×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CNS
CNS

Segment breakdown not available.

DCGO
DCGO

Transportation Services Segment$50.2M67%
Mobile Health Services Segment$24.8M33%

Related Comparisons